Monkeypox Declared a Public Health Emergency
Ever since the first European cases of monkeypox were confirmed in early May 2022, many suspected smallpox or monkeypox would become the next global pandemic to justify continued tyranny and the World Economic Forum’s Great Reset.Indeed, in early December 2021, media started signaling that smallpox might be the next pandemic. As it turns out, monkeypox1 is the same family as smallpox,2 but is nowhere nearly as lethal.
By the third week of July 2022, some 16,000 cases of monkeypox had been recorded across 75 countries, with the vast majority of cases occurring among homosexual and bisexual men. In the U.S., recorded cases were around 3,000, including two children.
As we saw with COVID-19, health authorities claim many of the infections have no known source of infection, suggesting it may be spreading in unknown ways. With COVID, they blamed it on “asymptomatic spread,” which was always a complete fallacy. Time will tell what they come up with here.
In other words, “here we go again,” as predicted. And, as with COVID, there’s evidence that we may not be dealing with something that arose accidentally and naturally.
As discussed by Dr. John Campbell in the featured video, the Wuhan Institute of Virology (WIV) in China and the National Institutes of Health in the U.S. have coincidentally been working on the monkeypox virus and its treatment9 for some time.
The Wuhan Institute of Virology published a study in February 2022, in which they describe creating a portion of a monkeypox genome from scratch in order to develop a PCR test for monkeypox diagnosis.
The NIH, which has identified monkeypox as a potential bioterrorism agent, is currently studying the safety and efficacy of an antiviral called tecovirimat for the treatment of monkeypox. The study in question began September 28, 2020, and will run through the end of September 2025.
Meanwhile, the WIV published a study10 in February 2022, in which they describe creating a portion of a monkeypox genome from scratch in order to develop a PCR test for monkeypox diagnosis.
As explained by Campbell, they created a section (fragment) of the monkeypox virus’ genome in order to use that as a quantitative polymerase chain-reactive (qPCR) template. Curiously, the paper states that, because there’s never been a monkeypox outbreak in China, “the viral genomic material required for qPCR detection is unavailable.”
So, they created a version of the monkeypox genome on their own, using synthetic techniques such as viral DNA recombination. They basically built a new genome by stitching it together using a variety of (presumably known) gene sequences. The new DNA construct is then reproduced by growing it in yeast, and that yeast is subsequently used to assess the veracity of the PCR test.
Not surprisingly, the U.S. Centers for Disease Control and Prevention is already urging those who may be at high risk for monkeypox — including those who attended the “Daddyland Festival” in Texas over the Fourth of July weekend — to get vaccinated.11
New York City started administering the smallpox vaccine in late June 2022. That’s not a typo. There is no specific monkeypox vaccine. They’re using the smallpox vaccine under the assumption that it might work because the two viruses are in the same family of pox viruses, but there’s very little evidence for this.12
No comments:
Post a Comment